Isoxazole, 3-bromo-4,5-dihydro-5,5-dimethyl-(882697-80-5)
- Name: Isoxazole, 3-bromo-4,5-dihydro-5,5-dimethyl-
- Synonyms:
- Molecular Formula:C5H8BrNO
- Molecular Weight:178.029
- CAS Registry Number:882697-80-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.882697-80-5 3-bromo-5,5-dimethyl-4,5-dihydroisoxazole
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] 
Assessed
SupplierTel:+86-189 8945 5137
Address:Jian Qiao Community, 789 Shenhua Road, Xihu District, Hangzhou, China, 310000
- Contact Suppliers
CAS No.882697-80-5 3-Bromo-5,5-Dimethyl-4,5-Dihydroisoxazole
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-173-20513646
Address:Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
- Contact Suppliers
Other Product
- 65527-62-0/N-Ethylnorlysergic Acid N,N-diethylaMide
- 345206-92-0/Sodium [4-(2-pyridinyl)-1-piperazinyl]acetate
- 1262526-46-4/3-Amino-N-cyclopropyl-2-hydroxy-4-methylpentanamide (non-preferred name)
- 1259854-82-4/1-(4-Fluorophenyl)-5-(2-oxo-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl)-1,5-pentanedione
- 479545-76-1/Tadalafil EP Impurity
- 2743-93-3/(1R,2S,5R)-7-Oxo-6-oxabicyclo[3.2.1]octane-2-carboxylic acid
- 123856-15-5/Naphthalene, 6-bromo-2-methoxy-1-nitro-
- 862429-66-1/Naphthalene, 1,3,6,8-tetramethoxy-2-methyl-
- 1241377-74-1/6-Bromonaphthalene-1,2-diamine
- 935552-37-7/Naphtho[1,8-cd]-1,2-dithiole-3-carboxaldehyde
- 518316-53-5/Methanimidamide, N'-[4-[2-(dimethylamino)ethenyl]-1,6-dihydro-5-nitro-6-oxo-1-[(phenylme thoxy)methyl]-2-pyrimidinyl]-N,N-dimethyl-
- 1312811-00-9/(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]carbonyl}-4-methylphenyl)-D-glucitol
- 788124-61-8/1-Pyrrolidinyl(4,5,6,7-tetrahydro-1H-benzimidazol-6-yl)methanone
- 518316-54-6/Methanimidamide, N'-[4,5-dihydro-4-oxo-3-[(phenylmethoxy)methyl]-3H-pyrrolo[3,2-d]pyrim idin-2-yl]-N,N-dimethyl-
- 640284-71-5/Methanimidamide, N',N'''-(4-cyano-1H-pyrazole-3,5-diyl)bis[N,N-dimethyl-
- 207849-65-8/Methanimidamide, N,N-dimethyl-N'-1H-pyrrolo[3,2-b]pyridin-5-yl-
- 1211593-39-3/2-(4-(4-bromophenyl)-1H-imidazol-2-yl)pyridine
- 656825-92-2/Isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]met hyl]thio]-4,5-dihydro-5,5-dimethyl-
- 1211593-45-1/N-(5-bromothiazol-4-yl)-2,2,2-trifluoroacetamide
- 882697-80-5/Isoxazole, 3-bromo-4,5-dihydro-5,5-dimethyl-
- 1075726-78-1/Benzyl 3-[(1R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]propanoate
- 1039932-36-9/[1-(4-bromophenyl)cyclobutyl]methanamine
- 1263279-50-0/5-Bromo-3-phenyl-1,2,4-oxadiazole
- 1211593-36-0/1-Pyridin-2-yl-cyclobutanecarbaldehyde
- 119403-01-9/Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-me thyl-2-[3-oxo-3-[[5-[(1-oxo-2-propenyl)oxy]pentyl]oxy]propyl]-, cis-
- 923032-37-5/RDEA119
- 85-63-2/(-)-laudanosine
- 64228-84-8/2(1H)-ISOQUINOLINEPROPANOIC ACID,1-[(3,4-DIMETHOXYPHENYL)METHYL]-3,4-DIHYDRO-6,7-DIMETHOXY-, 1,5-PENTANEDIYL ESTER, (R*,R*)-(-)-, ETHANEDIOATE
- 891494-64-7/SCH-900776
- 1259854-85-7/-(4-Fluorophenyl)-5-hydroxypentanoyl]-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3]oxazol-2-one